Given the contributory roles of multiple protein kinases in hepatocarcinogenesis, we hypothesized that disrupting the HSP90 and CDC37 chaperone complex may achieve anti-tumor effects in HCC, by inducing degradation and inhibiting phosphorylation of their client proteins kinases [16, 32, 33]. The gene discussed is CDC37; the disease is hepatocellular carcinoma.